The evolving role of Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia

por Gordon, Max J., Danilov, Alexey V.
Publicado 2021

Neddylation and anti-tumor immunity

por Wang, Xiaoguang, Best, Scott, Danilov, Alexey V.
Publicado 2021

Refractory Autoimmune Cytopenias Treated With Venetoclax

por Gordon, Max J., Maldonado, Edward, Danilov, Alexey V.
Publicado 2019

Translating the Biology of Diffuse Large B-cell Lymphoma Into Treatment

por Danilov, Alexey V, Magagnoli, Massimo, Matasar, Matthew J
Publicado 2022

Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Passé Yet?

por Danilov, Alexey V., Pagel, John M., Brown, Jennifer R., Hill, Brian T.
Publicado 2019

Urticarial linear IgA bullous dermatosis (LABD) as a presenting sign of chronic lymphocytic leukemia (CLL)

por Tiger, Jeffrey B., Rush, Jessica T., Barton, Dorothea T., Danilov, Alexey V., Chapman, M. Shane
Publicado 2015

A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale

por Gordon, Max J., Duan, Zhigang, Zhao, Hui, Nastoupil, Loretta, Ferrajoli, Alessandra, Danilov, Alexey V., Giordano, Sharon H.
Publicado 2023

Pevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis

por Paiva, Cody, Claire Godbersen, J., Rowland, Taylor, Danilova, Olga V., Danes, Christopher, Berger, Allison, Danilov, Alexey V.
Publicado 2017

A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocyti...

por Danilov, Alexey V., Spurgeon, Stephen E., Siddiqi, Tanya, Quinson, Anne-Marie, Maier, Daniela, Smith, Dionne, Brown, Jennifer R.
Publicado 2021

NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells

por Kittai, Adam S., Danilova, Olga V., Lam, Vi, Liu, Tingting, Bruss, Nur, Best, Scott, Fan, Guang, Danilov, Alexey V.
Publicado 2021

The CLL comorbidity index in a population-based cohort: a tool for clinical care and research

por Rotbain, Emelie C., Gordon, Max J., Vainer, Noomi, Frederiksen, Henrik, Hjalgrim, Henrik, Danilov, Alexey V., Niemann, Carsten U.
Publicado 2022

DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance

por Danilov, Alexey V., Neupane, Divas, Nagaraja, Archana Sidalaghatta, Feofanova, Elena V., Humphries, Leigh Ann, DiRenzo, James, Korc, Murray
Publicado 2011

Correction: DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance

por Danilov, Alexey V., Neupane, Divas, Nagaraja, Archana Sidalaghatta, Feofanova, Elena V., Humphries, Leigh Ann, DiRenzo, James, Korc, Murray
Publicado 2018

A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia

por Pooler, Darcy B., Ness, Dylan B., Danilov, Alexey V., Labrie, Bridget M., Tosteson, Tor D., Eastman, Alan, Lewis, Lionel D., Lansigan, Frederick
Publicado 2022

Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells

por Paiva, Cody, Godbersen, J. Claire, Soderquist, Ryan S., Rowland, Taylor, Kilmarx, Sumner, Spurgeon, Stephen E., Brown, Jennifer R., Srinivasa, Sreesha P., Danilov, Alexey V.
Publicado 2015

Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies

por Kittai, Adam S., Best, Scott, Thurlow, Bria, Lam, Vi, Hashiguchi, Taylor, Goodyear, Shaun, Persky, Daniel O., Okada, Craig, Park, Byung, Spurgeon, Stephen E., Danilov, Alexey V.
Publicado 2021

TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma

por Gordon, Max J., Bond, David A., Kittai, Adam S., Amirmokhtari, Neda, Steinbrunner, Abigail, Huffman, Allison, Orellana-Noia, Victor, Shouse, Geoffrey, Cohen, Jonathon B., Phillips, Tycel, Danilov, Alexey V.
Publicado 2023

SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia

por Paiva, Cody, Rowland, Taylor A., Sreekantham, Bhargava, Godbersen, Claire, Best, Scott R., Kaur, Prabhjot, Loriaux, Marc M., Spurgeon, Stephen E.F., Danilova, Olga V., Danilov, Alexey V.
Publicado 2017

CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma

por Thieme, Elana, Bruss, Nur, Sun, Duanchen, Dominguez, Edward C., Coleman, Daniel, Liu, Tingting, Roleder, Carly, Martinez, Melissa, Garcia-Mansfield, Krystine, Ball, Brian, Pirrotte, Patrick, Wang, Lili, Xia, Zheng, Danilov, Alexey V.
Publicado 2023

Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs

por Matasar, Matthew J., Luminari, Stefano, Barr, Paul M., Barta, Stefan K., Danilov, Alexey V., Hill, Brian T., Phillips, Tycel J., Jerkeman, Mats, Magagnoli, Massimo, Nastoupil, Loretta J., Persky, Daniel O., Okosun, Jessica
Publicado 2019